Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation.
1982; Lippincott Williams & Wilkins; Volume: 65; Issue: 6 Linguagem: Inglês
10.1161/01.cir.65.6.1163
ISSN1524-4539
AutoresJanice B. Schwartz, Deborah Keefe, Robert E. Kates, E Kirsten, D C Harrison,
Tópico(s)Plant-based Medicinal Research
ResumoHomeCirculationVol. 65, No. 6Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBAcute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation. J B Schwartz, D Keefe, R E Kates, E Kirsten and D C Harrison J B SchwartzJ B Schwartz , D KeefeD Keefe , R E KatesR E Kates , E KirstenE Kirsten and D C HarrisonD C Harrison Originally published1 Jun 1982https://doi.org/10.1161/01.CIR.65.6.1163Circulation. 1982;65:1163–1170 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Wiebe S, Giessmann T, Hohl K, Schmidt-Gerets S, Hauel E, Jambrecina A, Bader K, Ishiguro N, Taub M, Sharma A, Ebner T, Mikus G, Fromm M, Müller F and Stopfer P (2020) Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine, Clinical Pharmacokinetics, 10.1007/s40262-020-00907-w, 59:12, (1627-1639), Online publication date: 1-Dec-2020. (2016) Calcium channel blockers Meyler's Side Effects of Drugs, 10.1016/B978-0-444-53717-1.00437-6, (23-39), . (2016) Cardiac glycosides Meyler's Side Effects of Drugs, 10.1016/B978-0-444-53717-1.00456-X, (117-157), . (2009) ANTIDYSRHYTHMIC DRUGS Meyler's Side Effects of Cardiovascular Drugs, 10.1016/B978-0-444-53268-8.50006-5, (263-429), . (2009) Drugs Used to Treat Hypertension, Heart Failure, and Angina Pectoris Meyler's Side Effects of Cardiovascular Drugs, 10.1016/B978-0-444-53268-8.50004-1, (1-196), . Magro L, Conforti A, Del Zotti F, Leone R, Iorio M, Meneghelli I, Massignani D, Visonà E and Moretti U (2007) Identification of severe potential drug-drug interactions using an Italian general-practitioner database, European Journal of Clinical Pharmacology, 10.1007/s00228-007-0394-1, 64:3, (303-309), Online publication date: 1-Mar-2008. (2006) Calcium channel blockers Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 10.1016/B0-44-451005-2/01400-5, (598-610), . Freher M, Challapalli S, Pinto J, Schwartz J, Bonow R and Gheorgiade M (1999) Current status of calcium channel blockers in patients with cardiovascular disease, Current Problems in Cardiology, 10.1016/S0146-2806(99)90000-2, 24:5, (229-340), Online publication date: 1-May-1999. VERSCHRAAGEN M, KOKS C, SCHELLENS J and BEIJNEN J (1999) P-GLYCOPROTEIN SYSTEM AS A DETERMINANT OF DRUG INTERACTIONS: THE CASE OF DIGOXIN–VERAPAMIL, Pharmacological Research, 10.1006/phrs.1999.0535, 40:4, (301-306), Online publication date: 1-Oct-1999. RILEY R and PRITCHETT E (1997) Pharmacologic Management of Atrial Fibrillation, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.1997.tb00841.x, 8:7, (818-829), Online publication date: 1-Jul-1997. Blackshear J, Stambler B, Strauss W, Roy D, Dias V, Beach C and Ebener M (1996) Control of heart rate during transition from intravenous to oral diltiazem in atrial fibrillation or flutter, The American Journal of Cardiology, 10.1016/S0002-9149(96)00604-2, 78:11, (1246-1250), Online publication date: 1-Dec-1996. Mayer U, Wagenaar E, Beijnen J, Smit J, Meijer D, Asperen J, Borst P and Schinkel A (2012) Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdrla P-glycoprotein, British Journal of Pharmacology, 10.1111/j.1476-5381.1996.tb15775.x, 119:5, (1038-1044), Online publication date: 1-Nov-1996. Brignole M, Menozzi C and Gianfranchi L (1996) Control of Rapid Heart Rate in Patients with Atrial Fibrillation: Drugs or Ablation? Cardiac Arrhythmias 1995, 10.1007/978-88-470-2223-2_46, (236-241), . BRIGNOLE M and MENOZZI C (1996) Control of Rapid Heart Rate in Patients with Atrial Fibrillation: Drugs or Ablation?, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1996.tb03337.x, 19:3, (348-356), Online publication date: 1-Mar-1996. Rauch S, Stern T and Zusman R (1995) Neuropsychiatric Considerations in the Treatment of Hypertension, The International Journal of Psychiatry in Medicine, 10.2190/1NVX-5BHE-D1MX-AVVM, 21:3, (291-308), Online publication date: 1-Sep-1991. Channer K (2012) The drug treatment of atrial fibrillation., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1991.tb03898.x, 32:3, (267-273), Online publication date: 1-Sep-1991. Powell A, Horowitz J, Hasin Y, Syrjanen M, Horomidis S and Louis W (1990) Acute myocardial uptake of digoxin in humans: Correlation with hemodynamic and electrocardiographic effects, Journal of the American College of Cardiology, 10.1016/S0735-1097(10)80007-5, 15:6, (1238-1247), Online publication date: 1-May-1990. Trenk D, Hertrich F, Winkelmann B, Glauner T, Dieterich H and Jähnchen E (2013) Lack of Effect of Enoximone on the Pharmacokinetics of Digoxin in Patients with Congestive Heart Failure, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1990.tb03467.x, 30:3, (235-240), Online publication date: 1-Mar-1990. Rahimtoola S (1989) Perspective on valvular heart disease: An update, Journal of the American College of Cardiology, 10.1016/0735-1097(89)90047-8, 14:1, (1-23), Online publication date: 1-Jul-1989. SCHWARTZ J and HERRE J (1989) The Electrophysiological Effects of Alpha-Chloralose Anesthesia in the Intact Dog: (1) Alone and (2) in Combination with Verapamil, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1989.tb02661.x, 12:2, (283-293), Online publication date: 1-Feb-1989. Talajic M, Nayebpour M, Jing W and Nattel S (1989) Frequency-dependent effects of diltiazem on the atrioventricular node during experimental atrial fibrillation., Circulation, 80:2, (380-389), Online publication date: 1-Aug-1989. Atwood J, Myers J, Sullivan M, Forbes S, Pewen W and Froelicher V (1988) Diltiazem and Exercise Performance in Patients with Chronic Atrial Fibrillation, Chest, 10.1378/chest.93.1.20, 93:1, (20-25), Online publication date: 1-Jan-1988. Maragno I, Santostasi G, Gaion R, Trento M, Grion A, Miraglia G and Volta S (1988) Low- and medium-dose diltiazem in chronic atrial fibrillation: Comparison with digoxin and correlation with drug plasma levels, American Heart Journal, 10.1016/0002-8703(88)90610-2, 116:2, (385-392), Online publication date: 1-Aug-1988. Dunselman P, Scaf A, Kuntze C, Lie K and Wesseling H (1988) Digoxin-felodipine interaction in patients with congestive heart failure, European Journal of Clinical Pharmacology, 10.1007/BF00558239, 35:5, (461-465), . Edwin Atwood J, Sullivan M, Forbes S, Myers J, Pewen W, Olson H and Froelicher V (1987) Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation, Journal of the American College of Cardiology, 10.1016/S0735-1097(87)80013-X, 10:2, (314-320), Online publication date: 1-Aug-1987. Maragno I, Gianotti C, Tropeano P, Rodighiero V, Gaion R, Paleari C, Prandoni R and Menozzi L (1987) Verapamil-induced changes in digoxin kinetics in cirrhosis, European Journal of Clinical Pharmacology, 10.1007/BF00607580, 32:3, (309-311), . Antman E, Arnold J, Friedman P and Smith T (1987) Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: An appraisal of study methodology, Cardiovascular Drugs and Therapy, 10.1007/BF02125472, 1:2, (183-189), Online publication date: 1-Aug-1987. Hamer J (1987) Antiarrhythmic drugs Drugs for Heart Disease, 10.1007/978-1-4899-3294-5_1, (1-28), . Zoble R, Brewington J, Olukotun A and Gore R (1987) Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation, The American Journal of Cardiology, 10.1016/0002-9149(87)90707-7, 60:6, (39-45), Online publication date: 1-Aug-1987. Steinberg J, Katz R, Bren G, Buff L and Jacob Varghese P (1987) Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise, Journal of the American College of Cardiology, 10.1016/S0735-1097(87)80396-0, 9:2, (405-411), Online publication date: 1-Feb-1987. Boden W, More G, Sharma S, Bough E, Korr K, Young P and Shulman R (1986) No increase in serum digoxin concentration with high-dose diltiazem, The American Journal of Medicine, 10.1016/0002-9343(86)90293-7, 81:3, (425-428), Online publication date: 1-Sep-1986. Gordon M and Goldenberg L (2015) Clinical Digoxin Toxicity in the Aged in Association With Co-Administered Verapamil, Journal of the American Geriatrics Society, 10.1111/j.1532-5415.1986.tb04908.x, 34:9, (659-662), Online publication date: 1-Sep-1986. Keefe D, Miura D and Somberg J (1986) Supraventricular tachyarrhythmias: Their evaluation and therapy, American Heart Journal, 10.1016/0002-8703(86)90020-7, 111:6, (1150-1161), Online publication date: 1-Jun-1986. Kasmer R and Jones E (2016) Diltiazem-Nifedipine-Digoxin Interaction, Drug Intelligence & Clinical Pharmacy, 10.1177/106002808602001218, 20:12, (985-986), Online publication date: 1-Dec-1986. De Vito J and Friedman B (2012) Evaluation of the Pharmacodynamic and Pharmacokinetic Interaction Between Calcium Antagonists and Digoxin, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 10.1002/j.1875-9114.1986.tb03456.x, 6:2, (73-82), Online publication date: 4-Mar-1986. Keefe D, Ehrreich S and Levitt B (2013) Problems in New-Drug Development: Therapeutic Agents for Ventricular Arrhythmias, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1986.tb02950.x, 26:8, (562-566), Online publication date: 12-Nov-1986. North D, Mattern A and Hiser W (2016) The Influence of Diltiazem Hydrochloride on Trough Serum Digoxin Concentrations, Drug Intelligence & Clinical Pharmacy, 10.1177/106002808602000615, 20:6, (500-503), Online publication date: 1-Jun-1986. Roth A, Harrison E, Mitani G, Cohen J, Rahimtoola S and Elkayam U (1986) Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation., Circulation, 73:2, (316-324), Online publication date: 1-Feb-1986. Ochs H and Eichelbaum M (1985) Diltiazem, Verapamil und Chinidin als Mono- und Kombinationstherapie bei chronischem Vorhofflimmern Kombinationstherapie der Herzrhytmusstörungen mit Chinidin und Verapamil, 10.1007/978-3-642-85346-3_8, (103-114), . Elkayam U, Parikh K, Torkan B, Weber L, Cohen J and Rahimtoola S (1985) Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease, The American Journal of Cardiology, 10.1016/0002-9149(85)90511-9, 55:11, (1393-1395), Online publication date: 1-May-1985. Kenny J (1985) Calcium channel blocking agents and the heart., BMJ, 10.1136/bmj.291.6503.1150, 291:6503, (1150-1152), Online publication date: 26-Oct-1985. Ochs H, Anda L, Eichelbaum M and Greenblatt D (2013) Diltiazem, Verapamil, and Quinidine in Patients With Chronic Atrial Fibrillation, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1985.tb02826.x, 25:3, (204-209), Online publication date: 1-Apr-1985. Schwartz J (1985) Digoxin and nifedipine, The American Journal of Cardiology, 10.1016/0002-9149(85)91209-3, 55:12, (E31-E34), Online publication date: 1-May-1985. Watanabe A (1985) Role of the Autonomic Nervous System in the Generation of Supraventricular Tachyarrhythmias: Clues to Drug Selection Cardiac Arrhythmias: New Therapeutic Drugs and Devices, 10.1007/978-1-4613-2595-6_21, (307-314), . Somberg J (1985) Calcium channel blockers that prolong the QT interval, American Heart Journal, 10.1016/0002-8703(85)90628-3, 109:2, (416-421), Online publication date: 1-Feb-1985. Watanabe A (1985) Digitalis and the autonomic nervous system, Journal of the American College of Cardiology, 10.1016/S0735-1097(85)80461-7, 5:5, (35A-42A), Online publication date: 1-May-1985. McAllister R, Hamann S and Blouin R (1985) Pharmacokinetics of calcium-entry blockers, The American Journal of Cardiology, 10.1016/0002-9149(85)90611-3, 55:3, (B30-B40), Online publication date: 1-Jan-1985. Lawrence J (1985) Antianginal and β-adrenoceptor blocking drugs , 10.1016/S0378-6080(85)80023-4, (171-188), . Somberg J, Keefe D and Levitt B (2013) Digitalis: Its Place in Therapy, The Journal of Clinical Pharmacology, 10.1177/009127008502500711, 25:7, (555-559), Online publication date: 1-Oct-1985. Klieman R and Huckendubler Stephenson S CALCIUM ANTAGONISTS - DRUG INTERACTIONS, Drug Metabolism and Drug Interactions, 10.1515/DMDI.1985.5.2-3.193, 5:2-3 Schwartz J, Nielsen A and Griffin J (1985) Concentration-dependent enhancement of junctional pacemaker activity by verapamil in man., Circulation, 71:3, (450-457), Online publication date: 1-Mar-1985. Smith T, Antman E, Friedman P, Blatt C and Marsh J (1984) Part II Digitalis glycosides: Mechanisms and manifestations of toxicity, Progress in Cardiovascular Diseases, 10.1016/0033-0620(84)90014-8, 26:6, (495-540), Online publication date: 1-May-1984. Young G (1984) Calcium channel blockers in emergency medicine, Annals of Emergency Medicine, 10.1016/S0196-0644(84)80734-9, 13:9, (712-722), Online publication date: 1-Sep-1984. Perrot B, Danchin N and Terrier de la Chaise A (1984) Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy., Heart, 10.1136/hrt.51.3.352, 51:3, (352-354), Online publication date: 1-Mar-1984. Smith T, Antman E, Friedman P, Blatt C and Marsh J (1984) Part I Digitalis glycosides: Mechanisms and manifestations of toxicity, Progress in Cardiovascular Diseases, 10.1016/0033-0620(84)90012-4, 26:5, (413-458), Online publication date: 1-Mar-1984. Schwartz J, Jeang M, Raizner A, Griffin J and Wyndham C (1984) Accelerated junctional rhythms during oral verapamil therapy, American Heart Journal, 10.1016/0002-8703(84)90083-8, 107:3, (440-443), Online publication date: 1-Mar-1984. Schwartz J, Raizner A and Akers S (1984) The effect of nifedipine on serum digoxin concentrations in patients, American Heart Journal, 10.1016/0002-8703(84)90313-2, 107:4, (669-673), Online publication date: 1-Apr-1984. DiBianco R, Morganroth J, Freitag J, Ronan J, Lindgren K, Donohue D, Larca L, Chadda K and Olukotun A (1984) Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin, American Heart Journal, 10.1016/0002-8703(84)90592-1, 108:4, (1121-1127), Online publication date: 1-Oct-1984. Oetgen W, Sobol S, Tri T, Heydorn W and Rakita L (1984) Amiodarone-Digoxin Interaction, Chest, 10.1378/chest.86.1.75, 86:1, (75-79), Online publication date: 1-Jul-1984. Weinrauch L, Belok S and D'Elia J (1984) Decreased serum lithium during verapamil therapy, American Heart Journal, 10.1016/0002-8703(84)90776-2, 108:5, (1378-1380), Online publication date: 1-Nov-1984. Oyama Y, Fujii S, Kanda K, Akino E, Kawasaki H, Nagata M and Goto K (1984) Digoxin-diltiazem interaction, The American Journal of Cardiology, 10.1016/S0002-9149(84)91653-9, 53:10, (1480-1481), Online publication date: 1-May-1984. Keren G, Tepper D, Butler B, Maguire W, Willens H, Miura D and Somberg J (1984) Studies on the possible mechanisms of lidoflazine arrhythmogenicity, Journal of the American College of Cardiology, 10.1016/S0735-1097(84)80401-5, 4:4, (742-747), Online publication date: 1-Oct-1984. Kotzur J, Junglaß C, Weber M, Theisen K, Kremer G, Henkel B, Pfeiffer C, Ehrenthal W, Erbel R, Krämer G, Prellwitz W, Meyer J, Hoberg E, Richter S, Schwarz F, Katus H, Kübler W, Zeiher A, Bonzel T, Wollschläger H, Hohnloser S, Just H, Klepzig M, Baur X, Hauser F, Mernitz D, Fruhmann G, Strauer B, Konz K, Karsch K, Jacksch R, Seipel L, Ulbrich T, Jansen W, Osterspey A, Gabrielsen F, Tauchert M, Simon M, Hilger H, Strödter D, Bilgin Y, Löllgen H, Zeiher A, Wieland H, Bossaller C, Schober O, Meyer G, Sturm J, Hundeshagen H, Lichtlen P, Kuhlmann J, Marcin S, Stürzenhofecker P, Betz P, Schnellbacher K, Roskamm H, Mattern H, Fricke G, Heck I, Runkel W, Harms E, Orellano L, Kirchhoff P, Bönhof J, Linhart P, Eichstädt H, Gutmann M, Felix R, Schmutzler H, Schofer J, Stritzke P, Becher H, Mathey D, Krebber H, Spielmann R, Heuser L, Niehues B, Eckert H, Drexler H, Truog A, Zelis R, Kromer E, Riegger A, Liebau G, Saborowski F, Nachtsheim P, Griebenow R, Kropp J, Reske S, Stumpe K, Krück F, Kochsiek K, Maisch B, Romen W, Eigel P, Schmaltz A, Regitz V, Deeg P, Wüsten B, Hammel D, Brachmann J, Senges J, Gao T, Rizos I, Heuer H, Gülker H, Müller U, Bender F, Bethge C, Merx W, Recker S, Gebhardt-Seehausen U, Müllges W, Djonlagić H, Potratz J, Rimek A, Hackenjos B, Diederich K, Kikis D, Grötz J and Hossmann V (1984) Kardiologie 90. Kongreß, 10.1007/978-3-642-85457-6_66, (1365-1444), . Smith T, Antman E, Friedman P, Blatt C and Marsh J (1984) Part III Digitalis glycosides: Mechanisms and manifestations of toxicity, Progress in Cardiovascular Diseases, 10.1016/0033-0620(84)90018-5, 27:1, (21-56), Online publication date: 1-Jul-1984. Zatuchni J (1984) Verapamil-digoxin interaction, American Heart Journal, 10.1016/0002-8703(84)90635-5, 108:2, (412-413), Online publication date: 1-Aug-1984. Farringer J, Green J, O'Rourke R, Linn W and Clementi W (1984) Nifedipine-induced aiterations in serum quinidine concentrations, American Heart Journal, 10.1016/0002-8703(84)90717-8, 108:6, (1570-1572), Online publication date: 1-Dec-1984. Panidis I, Morganroth J and Baessler C (1983) Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis, The American Journal of Cardiology, 10.1016/0002-9149(83)90573-8, 52:10, (1197-1201), Online publication date: 1-Dec-1983. Lang R, Klein H, Weiss E, David D, Sareli P, Levy A, Guerrero J, Segni E and Kaplinsky E (1983) Superiority of Oral Verapamil Therapy to Digoxin in Treatment of Chronic Atrial Fibrillation, Chest, 10.1378/chest.83.3.491, 83:3, (491-499), Online publication date: 1-Mar-1983. Krikler D and Rowland E (1983) Clinical value of calcium antagonists in treatment of cardiovascular disorders, Journal of the American College of Cardiology, 10.1016/S0735-1097(83)80035-7, 1:1, (355-364), Online publication date: 1-Jan-1983. Schwartz J (1983) Verapamil in atrial fibrillation: The expected, the unexpected, and the unknown, American Heart Journal, 10.1016/0002-8703(83)90471-4, 106:1, (173-176), Online publication date: 1-Jul-1983. Gray Ellrodt A and Singh B (1983) Clinical applications of slow channel blocking compounds, Pharmacology & Therapeutics, 10.1016/0163-7258(83)90025-6, 23:1, (1-43), Online publication date: 1-Jan-1983. Packer M and Frishman W (1982) Verapamil therapy for stable and unstable angina pectoris: Calcium channel antagonists in perspective, The American Journal of Cardiology, 10.1016/0002-9149(82)91249-8, 50:4, (881-885), Online publication date: 1-Oct-1982. Klein H and Kaplinsky E (1982) Verapamil and digoxin: Their respective effects on atrial fibrillation and their interaction, The American Journal of Cardiology, 10.1016/0002-9149(82)91251-6, 50:4, (894-902), Online publication date: 1-Oct-1982. June 1, 1982Vol 65, Issue 6 Advertisement Article InformationMetrics Copyright © 1982 by American Heart Associationhttps://doi.org/10.1161/01.CIR.65.6.1163 Originally publishedJune 1, 1982 PDF download Advertisement
Referência(s)